DaVita Inc. (NYSE:DVA) Given Consensus Recommendation of “Hold” by Analysts

DaVita Inc. (NYSE:DVA) has earned an average rating of “Hold” from the six brokerages that are presently covering the stock, Marketbeat reports. One investment analyst has rated the stock with a sell recommendation, four have given a hold recommendation and one has given a buy recommendation to the company. The average 12 month price objective among brokers that have issued ratings on the stock in the last year is $166.33.

Several brokerages have commented on DVA. Cowen reissued a “hold” rating on shares of DaVita in a research report on Tuesday, February 18th. StockNews.com upgraded shares of DaVita from a “hold” rating to a “buy” rating in a report on Friday, April 25th. Barclays lifted their target price on shares of DaVita from $164.00 to $169.00 and gave the company an “equal weight” rating in a report on Tuesday, February 18th. Finally, Sanford C. Bernstein set a $184.00 price target on DaVita in a research note on Friday, February 21st.

DaVita Stock Down 0.0 %

Shares of NYSE DVA opened at $143.62 on Friday. The firm has a fifty day simple moving average of $145.85 and a two-hundred day simple moving average of $153.88. The firm has a market capitalization of $11.04 billion, a PE ratio of 13.37, a price-to-earnings-growth ratio of 1.07 and a beta of 1.14. The company has a current ratio of 1.26, a quick ratio of 1.21 and a debt-to-equity ratio of 23.18. DaVita has a 12 month low of $131.44 and a 12 month high of $179.60.

DaVita (NYSE:DVA) last issued its quarterly earnings data on Thursday, February 13th. The company reported $2.24 EPS for the quarter, topping the consensus estimate of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Equities analysts expect that DaVita will post 10.76 earnings per share for the current year.

Hedge Funds Weigh In On DaVita

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Arjuna Capital purchased a new position in shares of DaVita in the first quarter worth $1,269,000. ASR Vermogensbeheer N.V. bought a new position in DaVita during the 1st quarter valued at about $2,534,000. iA Global Asset Management Inc. boosted its holdings in shares of DaVita by 157.0% during the 1st quarter. iA Global Asset Management Inc. now owns 14,924 shares of the company’s stock valued at $2,283,000 after acquiring an additional 9,118 shares during the last quarter. PNC Financial Services Group Inc. grew its stake in shares of DaVita by 3.3% in the first quarter. PNC Financial Services Group Inc. now owns 13,273 shares of the company’s stock worth $2,030,000 after acquiring an additional 419 shares during the period. Finally, Blueshift Asset Management LLC purchased a new position in shares of DaVita during the first quarter valued at approximately $216,000. 90.12% of the stock is owned by institutional investors.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.